"Streptozocin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antibiotic that is produced by Stretomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals.
Descriptor ID |
D013311
|
MeSH Number(s) |
D02.654.692.768 D02.948.594.768 D09.408.051.900
|
Concept/Terms |
Streptozocin- Streptozocin
- Streptozotocine
- 2-Deoxy-2-((methylnitrosoamino)carbonyl)amino-D-glucose
- Streptozotocin
|
Below are MeSH descriptors whose meaning is more general than "Streptozocin".
Below are MeSH descriptors whose meaning is more specific than "Streptozocin".
This graph shows the total number of publications written about "Streptozocin" by people in this website by year, and whether "Streptozocin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 2 | 2 |
1996 | 1 | 0 | 1 |
1998 | 0 | 1 | 1 |
1999 | 0 | 1 | 1 |
2001 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
2003 | 0 | 2 | 2 |
2004 | 0 | 2 | 2 |
2005 | 1 | 1 | 2 |
2006 | 0 | 2 | 2 |
2007 | 0 | 2 | 2 |
2008 | 0 | 3 | 3 |
2009 | 0 | 1 | 1 |
2010 | 0 | 2 | 2 |
2011 | 0 | 1 | 1 |
2012 | 0 | 2 | 2 |
2013 | 1 | 2 | 3 |
2014 | 0 | 1 | 1 |
2015 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2018 | 1 | 3 | 4 |
2019 | 1 | 0 | 1 |
2021 | 1 | 1 | 2 |
2022 | 0 | 1 | 1 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Streptozocin" by people in Profiles.
-
Pentoxifylline protects memory performance in streptozotocin-induced diabetic rats. Brain Res. 2025 Jan 15; 1847:149319.
-
Design, synthesis, and biological evaluation of a small molecule oral agonist of the glucagon-like-peptide-1 receptor. J Biol Chem. 2022 05; 298(5):101889.
-
SGLT2 Inhibition by Dapagliflozin Attenuates Diabetic Ketoacidosis in Mice with Type-1 Diabetes. Cardiovasc Drugs Ther. 2022 12; 36(6):1091-1108.
-
Fluorouracil, Doxorubicin with Streptozocin and Subsequent Therapies in Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2022; 112(1):34-42.
-
Lycium barbarum Polysaccharides Improve Testicular Spermatogenic Function in Streptozotocin-Induced Diabetic Rats. Front Endocrinol (Lausanne). 2020; 11:164.
-
Streptozotocin-Induced Diabetic Neuropathic Pain Is Associated with Potentiated Calcium-Permeable AMPA Receptor Activity in the Spinal Cord. J Pharmacol Exp Ther. 2019 11; 371(2):242-249.
-
ASO Author Reflections: Role of Preoperative Chemotherapy in the Treatment of Pancreatic Neuroendocrine Liver Metastases. Ann Surg Oncol. 2018 12; 25(Suppl 3):792-793.
-
The Effects of Agrin Isoforms on Diabetic Neuropathic Pain in a Rat Streptozotocin Model. Anesth Analg. 2018 10; 127(4):1051-1057.
-
Diabetes Mellitus-Induced Long Noncoding RNA Dnm3os Regulates Macrophage Functions and Inflammation via Nuclear Mechanisms. Arterioscler Thromb Vasc Biol. 2018 08; 38(8):1806-1820.
-
Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases. Ann Surg Oncol. 2018 Jun; 25(6):1709-1715.